NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SoVarGen Co., Ltd.

SoVarGen Co., Ltd.

Private
DaejeonHealthcare & Life Scienceshttps://sovargen.com/main?lang=ko

Last Round

VC Round

Feb 11, 2026

Est. Valuation

$83.01M

Total Funding Raised

$40.89M

Company Overview

SoVarGen Co., Ltd. is a biotechnology company that develops antisense oligonucleotide and mRNA therapies for the treatment of intractable central nervous system diseases caused by brain somatic mutations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

antisense oligonucleotideASOdrug discoveryCNS diseasesprecision medicineAI drug discoverybiotechbrain somatic mutationsrare disease therapeuticstarget discoveryin silico drug designpharma licensingepilepsy treatmentgenomic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SoVarGen Co., Ltd. Comparables

Compare SoVarGen Co., Ltd. with similar companies based on industry and business-model similarity.

SoVarGen Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neumirna Therapeutics
82%
Vico Therapeutics
79%
Deep Genomics
74%

SoVarGen Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 11, 2026
VC RoundJul 1, 2025
Series BDec 3, 2020
Series ASep 1, 2018

SoVarGen Co., Ltd. Investors

Notable investors and investment history

SoVarGen Co., Ltd. investors
InvestorRounds
Premier PartnersVC Round
HB InvestmentSeries B
Korea Development BankVC Round
Forward Equity PartnersSeries B
Atinum InvestmentVC Round, Series B, Series A

SoVarGen Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SoVarGen Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SoVarGen Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDaejeon
Year Founded2018
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.